Skip to content

MI MAPA 2024 Fall Conference | Improving Obesity Diagnosis and Treatment Through Endocrinology and Primary Care Collaboration (AACE)

Elizabeth Bauer, MD, FACP

1.Name(Required.)
2.Email(Required.)
3.Did the session meet the stated learning objectives?(Required.)
Use this statement to answer Q4-6.
After participating in this educational activity, I have increased my ability to:
4.Recognize obesity as a chronic, complex, and progressive disease warranting diagnosis, early intervention, and long-term management.(Required.)
5.Apply evidence-based recommendations for treatment for patients with obesity (encompassing AOMs including GLP-1s, SGLT2 inhibitors, behavioral interventions, and bariatric surgery).(Required.)
6.Identify the appropriate treatement strategies and contraindications for anti-obesity medications for persons with concurrent conditions (e.g., diabetes, cardiovascular disease).(Required.)
7.Do you plan to make changes in your practice as a result of attending this activity?(Required.)
8.If yes, list any changes
9.What barriers, if any, do you anticipate facing when incorporating these changes?
Use this statementcare to answer Q10-12.
Please indicate your agreement/disagreement with the following statements.
10.The content will help me improve patient care.(Required.)
11.The activity increased my knowledge.(Required.)
12.The activity increased my competence.(Required.)
13.Was the speaker knowledgeable about the topic?(Required.)
14.Did you detect a speaker bias in favor of a specific product or drug?(Required.)
15.Overall, how would you rate the content of this session?(Required.)
16.What did you like most about this program?
17.How could we have improved this program?